SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

NCT00003223 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

NETWORK

Sponsor class

Stopped Closed due to poor accrual.

Conditions

Head and Neck Cancer

Interventions

DRUG: fenretinide

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]